is tirzepatide fda approved for obesity Study sees potential benefits of drug in tackling type 2 diabetes approves diabetes drug tirzepatide – GLP-1 medications are marketed to

No, combining them isnt recommended due to overlapping mechanisms

This can be particularly beneficial for individuals with type 2 diabetes, as excess weight is often a contributing factor to insulin resistance

Many sulfonamide derivatives of metformin exerted cytotoxicity in human breast cancer cells (MCF-7 or MDA-MB-231, or both) induced particularly by methylated phenyl sulfonamides and was associated with their ability to arrest the cell cycle in the G0/G1 phase and subsequently to cause apoptosis (Torunoglu et al., 2023)

R., Abdel-Daim, M

The post states that visual appearance does not indicate chemical integrity or sterility, so a vial can look completely unchanged and still be outside its 28-day window

Fitzpatrick RE, Rostan EF